Martin Currie Ltd. Boosts Position in Revvity, Inc. (NYSE:RVTY)

Martin Currie Ltd. lifted its holdings in Revvity, Inc. (NYSE:RVTY - Free Report) by 52.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 11,286 shares of the company's stock after buying an additional 3,902 shares during the quarter. Martin Currie Ltd.'s holdings in Revvity were worth $1,260,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of RVTY. Allstate Corp purchased a new stake in Revvity during the fourth quarter worth $407,000. Orion Portfolio Solutions LLC raised its position in shares of Revvity by 6.0% in the 4th quarter. Orion Portfolio Solutions LLC now owns 5,030 shares of the company's stock worth $561,000 after acquiring an additional 284 shares in the last quarter. Triodos Investment Management BV lifted its stake in shares of Revvity by 15.3% during the 4th quarter. Triodos Investment Management BV now owns 23,750 shares of the company's stock worth $2,651,000 after purchasing an additional 3,150 shares during the last quarter. Norges Bank bought a new stake in Revvity during the fourth quarter valued at about $127,801,000. Finally, UniSuper Management Pty Ltd grew its stake in Revvity by 24.9% in the fourth quarter. UniSuper Management Pty Ltd now owns 18,399 shares of the company's stock valued at $2,054,000 after purchasing an additional 3,671 shares during the last quarter. Hedge funds and other institutional investors own 86.65% of the company's stock.

Insider Transactions at Revvity

In other news, insider Joel S. Goldberg sold 15,170 shares of the company's stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $126.73, for a total value of $1,922,494.10. Following the completion of the sale, the insider now directly owns 33,400 shares of the company's stock, valued at approximately $4,232,782. This represents a 31.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Tajinder S. Vohra sold 5,492 shares of the stock in a transaction on Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total value of $641,520.52. Following the sale, the insider now directly owns 19,652 shares of the company's stock, valued at approximately $2,295,550.12. This represents a 21.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.68% of the company's stock.

Remove Ads

Analyst Ratings Changes

Several analysts have recently commented on the company. KeyCorp increased their price objective on Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Sanford C. Bernstein lowered Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price objective for the company. in a research note on Friday, January 10th. Raymond James restated an "outperform" rating and issued a $145.00 target price (up previously from $140.00) on shares of Revvity in a research note on Monday, February 3rd. Bank of America upgraded Revvity from a "neutral" rating to a "buy" rating and set a $138.00 price target for the company in a research report on Friday, December 13th. Finally, Barclays upped their price objective on Revvity from $135.00 to $140.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. Four analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $136.25.

Revvity Trading Down 4.6 %

RVTY stock traded down $4.93 during trading on Thursday, reaching $101.79. 331,298 shares of the stock were exchanged, compared to its average volume of 873,665. Revvity, Inc. has a 1 year low of $97.32 and a 1 year high of $129.50. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. The business has a 50 day moving average price of $114.20 and a 200-day moving average price of $116.84. The firm has a market capitalization of $12.23 billion, a price-to-earnings ratio of 46.06, a P/E/G ratio of 3.82 and a beta of 1.06.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same quarter in the previous year, the firm earned $1.25 EPS. On average, research analysts predict that Revvity, Inc. will post 4.94 earnings per share for the current year.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.28%. The ex-dividend date is Thursday, April 17th. Revvity's payout ratio is 12.67%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.